Navigation Links
Affymax Announces Phase 2 Clinical Trial Results of Once-Per-Month,Hematide for the Treatment of Anemia in Patients with Early- and,End-Stage Chronic Kidney Disease

nts previously treated with Epoetin Alfa were switched to Hematide once every four weeks. The mean baseline Hgb level, which was 11.5 g/dL at baseline, was maintained within +/- 1 g/dL at the end of six months of treatment. Hematide was generally well tolerated with an adverse event profile consistent with the chronic kidney disease patient population.

Anne-Marie Duliege, M.D., vice president, Clinical, Medical and Regulatory Affairs for Affymax added, "As we prepare for Phase 3 clinical trials for Hematide, these data support our goal to evaluate the product in a broad CKD patient population. The Phase 3 studies will assess the safety and efficacy of Hematide in these patient populations and will generate sufficient clinical data to assist physicians in optimizing anemia management in their patients."

About Hematide

Hematide is a novel synthetic, pegylated peptide that binds to and activates the erythropoietin receptor. The product is being developed for treatment of anemia in chronic kidney disease and cancer.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company developing novel peptide-based drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide(TM), is currently in Phase 2 clinical trials for the treatment of anemia associated with chronic kidney disease and cancer. For additional information, please visit www.affymax.com.

This release contains forward-looking statements, including statements regarding the timing, design and results of the Company's clinical trials and drug development program, the timing and likelihood of the commercialization of Hematide. The Company's actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties, including risks relating to the continued safety and efficacy of Hematide in clinical development, the potential for once per month dosing, regulator
'"/>




Page: 1 2 3

Related medicine technology :

1. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
2. Affymax Announces Results From Phase 2 Clinical Trial of Hematide for the Treatment of Anemia in Dialysis Patients
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
7. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
8. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
11. Protox Announces Positive Clinical Data from Prostate Cancer Study

Post Your Comments:
(Date:11/6/2009)..., DURHAM, N.C., Nov. 6 O...XBO) today announced that a previously approved re...t the start of trading on Monday, Nov. 9, 2009 on ...utics, Inc. shares will trade under the new symbol..., 69207P 20 9, when the split becomes effective. ,...
(Date:11/6/2009)..., SAN DIEGO, Nov. 6 Trius Therapeu...istration statement on Form S-1 with the U.S. Secu... proposed initial public offering of shares of its...e sold in the offering will be offered by the Comp...cting as sole book-running manager, Piper Jaffray ...
(Date:11/6/2009)..., SARASOTA, Fla., Nov. 6 ...unced that it has signed a definitive agreement to...prietary medical devices. The Verathon Board of D...ing is subject to customary regulatory approvals a...val. The parties expect the closing to be complet...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3New family focused model of depression care needed to minimize risks 48506 1New family focused model of depression care needed to minimize risks 48506 2New family focused model of depression care needed to minimize risks 48506 3RPD Media Wins Four Big W Awards by the Advertising Club of Westchester County 48503 1RPD Media Wins Four Big W Awards by the Advertising Club of Westchester County 48503 2FDA Panel Mulls Newer Antipsychotics for Kids 48499 1FDA Panel Mulls Newer Antipsychotics for Kids 48499 2FDA Panel Mulls Newer Antipsychotics for Kids 48499 3FDA Panel Mulls Newer Antipsychotics for Kids 48499 4
...ortsCoatings,today announced approximately 10 mill...with its industry-leading antimicrobial coating, T...feet in 2007., The exponential increase in demand...rs, including a 2007 report in the Journal of the ...icillin-resistant Staphlycoccus,aureas) is respons...
...e cartilage,injuries now have the opportunity to r...udy at TRIA Orthopaedic Center, in Bloomington, MN...covers the ends of your bones at a,joint such as t...e pain,swelling and catching. In the United States...of musculoskeletal-related physician visits in 200...
Other Medicine Technology:10 Million Square Feet of Turf Set to be Treated in 2008 in Response to MRSA Outbreaks Nationwide 2Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue 2Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue 3
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 K...h Insurance Plans (AHIP), released the following s..., "Health plans strongly support comprehensive hea...iscussion by proposing a complete overhaul of how ...e proposed guaranteed coverage, elimination of pre...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this a ...tion (AMA), the AMA President J. James Rohack, M.D...sicians from all state and medical specialty socie...y-making meeting, where health system reform will ...com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over ...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 S...press availability this afternoon following a Demo...nnon Caucus Room. Below are the Speaker,s opening...Yes, it was a great occasion for us to receive the...e will be making history with our vote and making ...
(Date:11/7/2009)... October 23-25th marked the 1...d celebrities fighting the battle against pediatri...e foundation and it,s efforts for many years. , ...) November 7, 2009 -- The weekend of October 23-25...her anglers and celebrities fighting the battle ag...
Breaking Medicine News(10 mins):Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 3
...g with candy cigarettes may favorably set the mind...te smokers . The study, reported in the J...nationally representative sample of 25,887 US adul...centages of adults who had regularly (often or ver...
... have found that patients with COPD, or chronic ob... stiffness. The researchers also found that those...ation of the respiratory disease, had even greater...ch results appear in the second issue for June 200...
... Cancer Center researchers helps explain how memor...he research shows lymph nodes are not just organs ...o are the sites where a major fight against the sp...se. This is why before vaccines were developed, ch...
...ormed a pair and played hide-and-seek Monday eveni...uch to the delight of astronomers and stargazers. ...sky, people - gazing at it from open fields, park... dozen amateur astronomers, explained the planetar...
... at risk of suffering broken bones, torn ligaments...or both pet owner and pet, there are veterinarians...n their feet. James Roush, an orthopedic surgeon a...s on small animals and repairs many different kind...
...comeback Tuesday morning as the sun shone bright o...l breeze and thick clouds making an appearance by ...erature recorded at 10.30 a.m. was a cool 33 degre...ng, discomfort levels had risen as well. "...
Other Medicine News:Health News:The Danger in Candy Cigarettes 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 2Health News:Premature Vascular and Bone Changes Occur in COPD Patients 3Health News:Memory T Cells Protect the Body from Viruses 2Health News:Some Common Human Injuries Also Common in Dogs 2Health News:Some Common Human Injuries Also Common in Dogs 3
42201 Tracheostomy Care Tray Tray
Soft Pack Trach Care Kit
Economy Trach Care Kit
Disposable Caps and Plugs
Medicine Products: